JUAN MIGUEL GARCIA PUEBLA

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease CAGUAS, PR NPI 1689021727

General Payments — all program years on this page

$3,902.89

  • Category: General Payments
  • Program years: PY2019–2023
  • Record count: 114
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $699.50 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $619.5119
Education $79.991

By paying entity

Latest program year (PY2023) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $775.4312
2020 $364.6118
2021 $758.6826
2022 $1,304.6738
2023 $699.5020

Records — PY2023 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1001272965 GlaxoSmithKline, LLC. $2.14 05/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001273595 GlaxoSmithKline, LLC. $10.42 03/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001274567 GlaxoSmithKline, LLC. $108.29 03/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001275023 GlaxoSmithKline, LLC. $84.95 03/29/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1001275059 GlaxoSmithKline, LLC. $33.75 03/29/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1011739049 AstraZeneca Pharmaceuticals LP $19.00 02/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014874627 AstraZeneca Pharmaceuticals LP $18.90 07/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1034128073 ANI Pharmaceuticals, Inc. $25.00 05/05/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1042832209 Mallinckrodt Hospital Products Inc. $37.50 03/31/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049354833 PFIZER INC. $26.68 04/28/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049374514 PFIZER INC. $24.90 01/27/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1050463743 SANOFI-AVENTIS U.S. LLC $79.99 02/17/2023 Education Undisputed 01/23/2026 View at CMS
1050463755 GENZYME CORPORATION $34.09 02/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1050959577 United Therapeutics Corporation $25.00 02/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1050959579 United Therapeutics Corporation $25.00 02/28/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1055390337 Takeda Pharmaceuticals U.S.A., Inc. $24.90 02/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1055390339 Takeda Pharmaceuticals U.S.A., Inc. $28.46 03/03/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996506861 Boehringer Ingelheim Pharmaceuticals, Inc. $34.09 03/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996506865 Boehringer Ingelheim Pharmaceuticals, Inc. $29.17 02/03/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
997124327 Boehringer Ingelheim Pharmaceuticals, Inc. $27.27 03/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.